HBV Core Particles Allow the Insertion and Surface Exposure of the Entire Potentially Protective Region of Puumala Hantavirus Nucleocapsid Protein
暂无分享,去创建一个
D. Krüger | H. Gelderblom | R. Ulrich | S. Biel | H. Meisel | E. Nugel | D. Koletzki
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] D. Krüger,et al. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. , 1999, Journal of biotechnology.
[3] D. Krüger,et al. Characterization of Potential Insertion Sites in the Core Antigen of Hepatitis B Virus by the Use of a Short-Sized Model Epitope1 , 1999, Intervirology.
[4] D. Krüger,et al. Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. , 1997, The Journal of general virology.
[5] B. Hjelle,et al. Hantaviruses: a global disease problem. , 1997, Emerging infectious diseases.
[6] A. Vaheri,et al. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. , 1996, Virology.
[7] H. Lehvaslaiho,et al. Human B‐cell epitopes of puumala virus nucleocapsid protein, the major antigen in early serological response , 1995, Journal of medical virology.
[8] B. Hjelle,et al. Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein , 1995, Journal of virology.
[9] R. Wirtz,et al. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes , 1994, The Journal of experimental medicine.
[10] C. Schmaljohn. Prospects for vaccines to control viruses in the family Bunyaviridae , 1994 .
[11] P. Pumpens,et al. Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. , 1994, Virology.
[12] F. Minion,et al. Enhanced readthrough of opal (UGA) stop codons and production of Mycoplasma pneumoniae P1 epitopes in Escherichia coli. , 1993, Gene.
[13] P. Pumpens,et al. Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen , 1993, Journal of virology.
[14] G. Darai,et al. A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome , 1993, Journal of clinical microbiology.
[15] Å. Lundkvist,et al. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. , 1991, The Journal of general virology.
[16] B. Clarke,et al. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. , 1991, Vaccine.
[17] J. Dalrymple,et al. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants , 1990, Journal of virology.
[18] B. Clarke,et al. Expression in Yeast of Amino-Terminal Peptide Fusions to Hepatitis B Core Antigen and Their Immunological Properties , 1990, Bio/Technology.
[19] L. Zentilin,et al. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids , 1989, Journal of virology.
[20] H. Gelderblom,et al. The structure of group II adenoviruses. , 1967, The Journal of general virology.
[21] D. Krüger,et al. Core particles of hepatitis B virus as carrier for foreign epitopes. , 1998, Advances in virus research.
[22] D. Krüger,et al. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. , 1998, Vaccine.
[23] P. Pumpens,et al. Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen. , 1996, Intervirology.
[24] L. Bell-Sakyi,et al. Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial. , 1995, Vaccine.
[25] R. Crowther,et al. Hepatitis B virus core particles as epitope carriers. , 1995, Intervirology.
[26] F. Schödel,et al. Hepatitis B virus core particles as a vaccine carrier moiety. , 1994, International reviews of immunology.
[27] A. von Brunn,et al. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles. , 1993, Vaccine.
[28] F. Schödel. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes. , 1992, Advances in virus research.
[29] J. Playfair. Immunity to malaria. , 1982, British medical bulletin.